Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...

DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or ...

Even with the same cancer diagnosis personalised treatments are essential due to variations in patient health cancer ...

Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

Susan G. Komen: Quality of Life After Breast Cancer Treatment. National Cancer Institute: Complementary and Alternative ...

"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...

Alarming rates of secondary breast cancer are on the rise, with the figure increasing year on year since 2018 so it's more important than ever to know where it is most likely to occur and what to look ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

DATROWAY Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer ...